Combination Testing of Cediranib (AZD2171) Against Childhood Cancer Models by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.23159
Full Text
Open PDFAbstract
Available in full text
Date
April 29, 2011
Authors
Publisher
Wiley